Invesaro

Stocks Comparison

Staar Surgical vs Warby Parker: revenue, profit, margins and growth compared

Staar Surgical brought in $239.4M of revenue in fiscal 2025, Warby Parker $871.9M in fiscal 2025. Revenue changed by -23.7% at Staar Surgical and +13.0% at Warby Parker on the year before, so Warby Parker grew faster. Staar Surgical kept -33.6% of its revenue as net profit, Warby Parker 0.2%. Free cash flow was -$40.1M at Staar Surgical and $43.7M at Warby Parker.

Side by side, latest fiscal year

STAAWRBY
Fiscal year endedFY2025 (January 2, 2026)FY2025 (December 31, 2025)
Revenue$239.4M$871.9M
Revenue growth-23.7%+13.0%
Net income-$80.4M$1.6M
Net margin-33.6%0.2%
Free cash flow-$40.1M$43.7M
Free cash flow margin-16.7%5.0%
Earnings per share (diluted)-$1.62$0.01
Cash$153.2M$286.4M
Debtn/an/a
Price to earningsn/a2671.0
Market value$1B$3.3B
Dividend yieldn/an/a
Rank by revenue in sector#239 of 523 · Health care#155 of 523 · Health care

Over the years

Revenue
STAA FY2018: $124MSTAA FY2019: $150.2MSTAA FY2020: $163.5MSTAA FY2021: $230.5MSTAA FY2022: $239.4MSTAA FY2023: $322.4MSTAA FY2024: $313.9MSTAA FY2025: $239.4MWRBY FY2019: $370.5MWRBY FY2021: $393.7MWRBY FY2021: $540.8MWRBY FY2022: $598.1MWRBY FY2023: $669.8MWRBY FY2024: $771.3MWRBY FY2025: $871.9MFY18FY19FY20FY21FY22FY23FY24FY25
STAA $239.4MWRBY $871.9M
Net income
STAA FY2018: $5MSTAA FY2019: $14MSTAA FY2020: $5.9MSTAA FY2021: $27.5MSTAA FY2022: $39.7MSTAA FY2023: $21.3MSTAA FY2024: -$20.2MSTAA FY2025: -$80.4MWRBY FY2019: $0WRBY FY2021: -$55.9MWRBY FY2021: -$144.3MWRBY FY2022: -$110.4MWRBY FY2023: -$63.2MWRBY FY2024: -$20.4MWRBY FY2025: $1.6MFY18FY19FY20FY21FY22FY23FY24FY25
STAA -$80.4MWRBY $1.6M
Net margin
STAA FY2018: 4.0%STAA FY2019: 9.4%STAA FY2020: 3.6%STAA FY2021: 11.9%STAA FY2022: 16.6%STAA FY2023: 6.6%STAA FY2024: -6.4%STAA FY2025: -33.6%WRBY FY2019: 0.0%WRBY FY2021: -14.2%WRBY FY2021: -26.7%WRBY FY2022: -18.5%WRBY FY2023: -9.4%WRBY FY2024: -2.6%WRBY FY2025: 0.2%FY18FY19FY20FY21FY22FY23FY24FY25
STAA -33.6%WRBY 0.2%
Revenue growth
STAA FY2019: +21.2%STAA FY2020: +8.8%STAA FY2021: +41.0%STAA FY2022: +3.9%STAA FY2023: +34.7%STAA FY2024: -2.6%STAA FY2025: -23.7%WRBY FY2021: +6.3%WRBY FY2021: +37.4%WRBY FY2022: +10.6%WRBY FY2023: +12.0%WRBY FY2024: +15.2%WRBY FY2025: +13.0%FY19FY20FY21FY22FY23FY24FY25
STAA -23.7%WRBY +13.0%
Free cash flow
STAA FY2018: $10.5MSTAA FY2019: $15.7MSTAA FY2020: $12.5MSTAA FY2021: $30.3MSTAA FY2022: $17.6MSTAA FY2023: -$3.6MSTAA FY2024: -$7.7MSTAA FY2025: -$40.1MWRBY FY2019: -$11.2MWRBY FY2021: $12.7MWRBY FY2021: -$80.5MWRBY FY2022: -$49.8MWRBY FY2023: $7.3MWRBY FY2024: $34.7MWRBY FY2025: $43.7MFY18FY19FY20FY21FY22FY23FY24FY25
STAA -$40.1MWRBY $43.7M

Fiscal years as each company reports them; the two may end in different months.

Questions about Staar Surgical and Warby Parker

Which is bigger by revenue, Staar Surgical or Warby Parker?

Warby Parker is bigger by revenue: $871.9M in fiscal 2025, against $239.4M for Staar Surgical in fiscal 2025.

Which keeps more of its revenue as profit, Staar Surgical or Warby Parker?

Staar Surgical had a net margin of -33.6% in fiscal 2025; Warby Parker had 0.2% in fiscal 2025.

Which grew revenue faster, Staar Surgical or Warby Parker?

In their latest fiscal years revenue changed by -23.7% at Staar Surgical and +13.0% at Warby Parker.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies